As a publicly funded entity and a national drug development platform, EDDC’s Governing Board comprises members from key public agencies as well as former industry veterans.
Prof. William ChinCo-Chair
Emeritus Bertarelli Professor of Translational Medical Science Harvard Medical SchoolFormerly SVP Discovery Research, Eli Lilly
Prof. Benjamin SeetCo-ChairGroup Chief Research OfficerNational Healthcare Group
Prof Damian O’ConnellChief Executive Officer, Experimental Drug Development Centre (EDDC), A*STAR
Prof Tan Sze WeeAssistant Chief Executive, Enterprise, A*STAR
Mr Beh Kian TeikDeputy Chief Executive Officer, National Research Foundation (NRF)
Dr Lisa OoiVice President, Strategy (Health and Wellness), Economic Development Board (EDB)
Dr Danny SoonChief Executive Officer, Consortium for Clinical Research and Innovation Singapore (CRIS), MOH
A/Prof Tan Say BengExecutive Director, National Medical Research Council (NMRC)
Prof Ng Huck HuiAssistant Chief Executive Biomedical Research Council (BMRC), A*STAR
Audrey LokDirector, Healthcare & Biomedical, Enterprise Singapore (ESG)
Dr Andreas WallnoeferPartner Investor, Jeito CapitalFormer SVP & Global Head of Development, Hoffman-La Roche
Portfolio Review Committee (PRC)EDDC’s portfolio projects and platforms are reviewed by a PRC, comprising industry veterans and eminent scientists. The PRC also provides advice and recommendations to the Governing Board.
We are searching for individuals who dare push the boundaries of science and technology.If you know of brilliant minds in your midst, nominate them now for the nation’s highest honour in Science and Technology – The
President’s Science and Technology Awards 2022.
Nominations close on 17 May 2022.